A citation-based method for searching scientific literature

Yibei Zhu, Songguang Ju, Elizabeth Chen, Shao Dai, Changyou Li, Penelope Morel, Lin Liu, Xueguang Zhang, Binfeng Lu. J Immunol 2010
Times Cited: 124







List of co-cited articles
718 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Control of effector CD8+ T cell function by the transcription factor Eomesodermin.
Erika L Pearce, Alan C Mullen, Gislâine A Martins, Connie M Krawczyk, Anne S Hutchins, Valerie P Zediak, Monica Banica, Catherine B DiCioccio, Darrick A Gross, Chai-An Mao,[...]. Science 2003
728
35

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.
Andrew M Intlekofer, Naofumi Takemoto, E John Wherry, Sarah A Longworth, John T Northrup, Vikram R Palanivel, Alan C Mullen, Christopher R Gasink, Susan M Kaech, Joseph D Miller,[...]. Nat Immunol 2005
878
27

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Jérôme Galon, Anne Costes, Fatima Sanchez-Cabo, Amos Kirilovsky, Bernhard Mlecnik, Christine Lagorce-Pagès, Marie Tosolini, Matthieu Camus, Anne Berger, Philippe Wind,[...]. Science 2006
18

Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.
Michael A Paley, Daniela C Kroy, Pamela M Odorizzi, Jonathan B Johnnidis, Douglas V Dolfi, Burton E Barnett, Elizabeth K Bikoff, Elizabeth J Robertson, Georg M Lauer, Steven L Reiner,[...]. Science 2012
571
17

Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.
Andrew M Intlekofer, Arnob Banerjee, Naofumi Takemoto, Scott M Gordon, Caitlin S Dejong, Haina Shin, Christopher A Hunter, E John Wherry, Tullia Lindsten, Steven L Reiner. Science 2008
302
16

Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.
Nikhil S Joshi, Weiguo Cui, Anmol Chandele, Heung Kyu Lee, David R Urso, James Hagman, Laurent Gapin, Susan M Kaech. Immunity 2007
14

A novel transcription factor, T-bet, directs Th1 lineage commitment.
S J Szabo, S T Kim, G L Costa, X Zhang, C G Fathman, L H Glimcher. Cell 2000
13

Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.
Matthew E Pipkin, Jilian A Sacks, Fernando Cruz-Guilloty, Mathias G Lichtenheld, Michael J Bevan, Anjana Rao. Immunity 2010
534
13

Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
Arnob Banerjee, Scott M Gordon, Andrew M Intlekofer, Michael A Paley, Erin C Mooney, Tulia Lindsten, E John Wherry, Steven L Reiner. J Immunol 2010
283
12

T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.
Gang Li, Qianting Yang, Yibei Zhu, Hong-Rui Wang, Xinchun Chen, Xueguang Zhang, Binfeng Lu. PLoS One 2013
38
31

Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.
Naofumi Takemoto, Andrew M Intlekofer, John T Northrup, E John Wherry, Steven L Reiner. J Immunol 2006
259
11

T cell exhaustion.
E John Wherry. Nat Immunol 2011
11

T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
Cécile Daussy, Fabrice Faure, Katia Mayol, Sébastien Viel, Georg Gasteiger, Emily Charrier, Jacques Bienvenu, Thomas Henry, Emilie Debien, Uzma A Hasan,[...]. J Exp Med 2014
375
11

Antigen-driven effector CD8 T cell function regulated by T-bet.
Brandon M Sullivan, Amy Juedes, Susanne J Szabo, Matthias von Herrath, Laurie H Glimcher. Proc Natl Acad Sci U S A 2003
306
10

Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.
Charlly Kao, Kenneth J Oestreich, Michael A Paley, Alison Crawford, Jill M Angelosanto, Mohammed-Alkhatim A Ali, Andrew M Intlekofer, Jeremy M Boss, Steven L Reiner, Amy S Weinmann,[...]. Nat Immunol 2011
335
10

Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.
Fernando Cruz-Guilloty, Matthew E Pipkin, Ivana M Djuretic, Ditsa Levanon, Joseph Lotem, Mathias G Lichtenheld, Yoram Groner, Anjana Rao. J Exp Med 2009
334
10

The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.
Scott M Gordon, Julie Chaix, Levi J Rupp, Junmin Wu, Sharline Madera, Joseph C Sun, Tullia Lindsten, Steven L Reiner. Immunity 2012
505
10


Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
9

Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer.
Lu-jun Chen, Xiao Zheng, Yue-ping Shen, Yi-bei Zhu, Qing Li, Junjun Chen, Rui Xia, Shu-ming Zhou, Chang-ping Wu, Xue-guang Zhang,[...]. Cancer Immunol Immunother 2013
64
12

T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection.
Marcus Buggert, Johanna Tauriainen, Takuya Yamamoto, Juliet Frederiksen, Martin A Ivarsson, Jakob Michaëlsson, Ole Lund, Bo Hejdeman, Marianne Jansson, Anders Sönnerborg,[...]. PLoS Pathog 2014
193
8

Molecular and cellular insights into T cell exhaustion.
E John Wherry, Makoto Kurachi. Nat Rev Immunol 2015
8

High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells.
Jing Li, Yi He, Jing Hao, Ling Ni, Chen Dong. Front Immunol 2018
76
10

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin.
Michael A Curran, Theresa L Geiger, Welby Montalvo, Myoungjoo Kim, Steven L Reiner, Aymen Al-Shamkhani, Joseph C Sun, James P Allison. J Exp Med 2013
112
7

Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.
Travis A Doering, Alison Crawford, Jill M Angelosanto, Michael A Paley, Carly G Ziegler, E John Wherry. Immunity 2012
337
7

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
E John Wherry, Sang-Jun Ha, Susan M Kaech, W Nicholas Haining, Surojit Sarkar, Vandana Kalia, Shruti Subramaniam, Joseph N Blattman, Daniel L Barber, Rafi Ahmed. Immunity 2007
7

Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.
Rachel L Rutishauser, Gislâine A Martins, Sergey Kalachikov, Anmol Chandele, Ian A Parish, Eric Meffre, Joshy Jacob, Kathryn Calame, Susan M Kaech. Immunity 2009
416
7

T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells.
Michael J Townsend, Amy S Weinmann, Jennifer L Matsuda, Rachelle Salomon, Peggy J Farnham, Christine A Biron, Laurent Gapin, Laurie H Glimcher. Immunity 2004
561
7

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
Xin Gao, Xuefeng Wang, Qianting Yang, Xin Zhao, Wen Wen, Gang Li, Junfeng Lu, Wenxin Qin, Yuan Qi, Fang Xie,[...]. J Immunol 2015
146
7

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, Susanna S Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nic Waddell, Stephen J Blake,[...]. Nat Immunol 2017
355
7

Nivolumab plus ipilimumab in advanced melanoma.
Jedd D Wolchok, Harriet Kluger, Margaret K Callahan, Michael A Postow, Naiyer A Rizvi, Alexander M Lesokhin, Neil H Segal, Charlotte E Ariyan, Ruth-Ann Gordon, Kathleen Reed,[...]. N Engl J Med 2013
6

Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.
Melissa M Berrien-Elliott, Jinyun Yuan, Lauryn E Swier, Stephanie R Jackson, Collin L Chen, Maureen J Donlin, Ryan M Teague. Cancer Immunol Res 2015
25
24


T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate.
Laura K Mackay, Erica Wynne-Jones, David Freestone, Daniel G Pellicci, Lisa A Mielke, Dane M Newman, Asolina Braun, Frederick Masson, Axel Kallies, Gabrielle T Belz,[...]. Immunity 2015
329
6

Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.
Christoph S N Klose, Melanie Flach, Luisa Möhle, Leif Rogell, Thomas Hoyler, Karolina Ebert, Carola Fabiunke, Dietmar Pfeifer, Veronika Sexl, Diogo Fonseca-Pereira,[...]. Cell 2014
735
6

Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes.
Laura K Mackay, Martina Minnich, Natasja A M Kragten, Yang Liao, Benjamin Nota, Cyril Seillet, Ali Zaid, Kevin Man, Simon Preston, David Freestone,[...]. Science 2016
526
6

Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
Olga Pikovskaya, Julie Chaix, Nyanza J Rothman, Amélie Collins, Yen-Hua Chen, Anna M Scipioni, Eric Vivier, Steven L Reiner. J Immunol 2016
78
7

Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.
Victor S Cortez, Luisa Cervantes-Barragan, Michelle L Robinette, Jennifer K Bando, Yaming Wang, Theresa L Geiger, Susan Gilfillan, Anja Fuchs, Eric Vivier, Joe C Sun,[...]. Immunity 2016
160
6

Maturation of mouse NK cells is a 4-stage developmental program.
Laura Chiossone, Julie Chaix, Nicolas Fuseri, Claude Roth, Eric Vivier, Thierry Walzer. Blood 2009
507
6

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.
Emilie Narni-Mancinelli, Julie Chaix, Aurore Fenis, Yann M Kerdiles, Nadia Yessaad, Ana Reynders, Claude Gregoire, Herve Luche, Sophie Ugolini, Elena Tomasello,[...]. Proc Natl Acad Sci U S A 2011
225
6

Eomesodermin is required for mouse trophoblast development and mesoderm formation.
A P Russ, S Wattler, W H Colledge, S A Aparicio, M B Carlton, J J Pearce, S C Barton, M A Surani, K Ryan, M C Nehls,[...]. Nature 2000
462
5

Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
Andrew M Intlekofer, Naofumi Takemoto, Charlly Kao, Arnob Banerjee, Felix Schambach, John K Northrop, Hao Shen, E John Wherry, Steven L Reiner. J Exp Med 2007
217
5


Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
Rajesh R Rao, Qingsheng Li, Melanie R Gubbels Bupp, Protul A Shrikant. Immunity 2012
194
5

Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
Koji Eshima, Sayuri Chiba, Harumi Suzuki, Kenichi Kokubo, Hirosuke Kobayashi, Misao Iizuka, Kazuya Iwabuchi, Nobukata Shinohara. Immunol Lett 2012
45
11

Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Ivan P Jovanovic, Nada N Pejnovic, Gordana D Radosavljevic, Jelena M Pantic, Marija Z Milovanovic, Nebojsa N Arsenijevic, Miodrag L Lukic. Int J Cancer 2014
212
5

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Jochen Schmitz, Alexander Owyang, Elizabeth Oldham, Yaoli Song, Erin Murphy, Terril K McClanahan, Gerard Zurawski, Mehrdad Moshrefi, Jinzhong Qin, Xiaoxia Li,[...]. Immunity 2005
5


Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
5

Disease-associated functions of IL-33: the new kid in the IL-1 family.
Foo Y Liew, Nick I Pitman, Iain B McInnes. Nat Rev Immunol 2010
733
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.